ArticleThoracic cancer2018

Combined therapy with osimertinib and afatinib in a lung adenocarcinoma patient with EGFR T790M mutation and multiple HER2 alterations after resistance to icotinib: A case report.

Ping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.